Fibrogen Inc. buy BiotechBee
Start price
19.02.24
/
60%
€2.14
Target price
31.07.27
€6.00
Performance (%)
-44.67%
End price
26.05.24
€1.18
Summary
This prediction ended on 26.05.24 with a price of €1.18. Massive losses of -44.67% were the result for the BUY prediction by BiotechBee. BiotechBee has a follow-up prediction for Fibrogen Inc. where he still thinks Fibrogen Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fibrogen Inc. | 4.872% | 4.872% |
iShares Core DAX® | 0.597% | 3.083% |
iShares Nasdaq 100 | 0.899% | 5.338% |
iShares Nikkei 225® | 1.775% | -1.206% |
iShares S&P 500 | 0.990% | 3.500% |
According to BiotechBee what are the pros and cons of Fibrogen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Fibrogen Inc. diskutieren
Buy mit Kursziel 6,0
In the thread Trading Fibrogen Inc.
Buy beendet
Current prediction by BiotechBee for Fibrogen Inc.
Fibrogen Inc.
Start price
Target price
Perf. (%)
€1.18
26.05.24
26.05.24
€4.00
31.01.26
31.01.26
-14.53%
05.06.24
05.06.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Fibrogen Inc.
Fibrogen Inc.
Start price
Target price
Perf. (%)
€0.88
25.01.24
25.01.24
€1.30
25.01.25
25.01.25
143.18%
19.02.24
19.02.24
Could be very worthwhile Investment >20% year